News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orion Genomics To Use Genomics Collaborative's Tissue Samples For Cancer Biomarker Discovery



5/4/2006 4:52:36 PM

NEW YORK, May 4 (GenomeWeb News) - Genomics Collaborative, a division of SeraCare Life Sciences, said today that it will provide Orion Genomics with annotated clinical tumor tissue specimens for use in Orion's cancer biomarker discovery and validation program. Orion Genomics, a developer of DNA-methylation-based molecular diagnostics, will screen the tissue samples to discover and validate epigenetic biomarkers that are indicative of the presence and stage of disease, Genomics Collaborative said. The deal is the second procurement agreement between the two firms. Additional terms were not disclosed.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES